XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Sep. 25, 2021
Sep. 26, 2020
Cash flows from operating activities:    
Net income (loss) $ 358.0 $ (166.8)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 113.1 125.2
Deferred income tax benefit (0.1) (86.9)
Non-cash stock-based compensation expense 40.6 34.6
Non-cash impairment of assets 19.3 33.1
Bad debt expense reversals (0.9) (25.4)
Other non-cash charges (benefits) 1.8 (2.1)
Changes in operating assets and liabilities:    
Accounts receivable 26.6 (49.7)
Inventories (199.0) (129.3)
Prepaid expenses and other current assets (17.7) 11.1
Accounts payable and accrued liabilities 145.7 219.6
Income tax receivables and payables 6.2 12.8
Other balance sheet changes (29.4) 11.1
Net cash provided by (used in) operating activities 464.2 (12.7)
Cash flows from investing activities:    
Capital expenditures (63.4) (53.9)
Purchases of investments (756.4) (407.0)
Proceeds from sales and maturities of investments 279.5 471.5
Settlement of net investment hedges 0.0 3.7
Other investing activities (2.1) (0.5)
Net cash provided by (used in) investing activities (542.4) 13.8
Cash flows from financing activities:    
Repayments of credit facility borrowings 0.0 (475.0)
Proceeds from issuance of long-term debt 0.0 1,241.9
Repayments of long-term debt 0.0 (300.0)
Payments of finance lease obligations (11.7) (5.7)
Payments of dividends (50.5) (49.8)
Repurchases of common stock, including shares surrendered for tax withholdings (39.9) (35.5)
Other financing activities 0.0 (8.6)
Net cash provided by (used in) financing activities (102.1) 367.3
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (11.0) 23.6
Net increase (decrease) in cash, cash equivalents, and restricted cash (191.3) 392.0
Cash, cash equivalents, and restricted cash at beginning of period 2,588.0 1,629.8
Cash, cash equivalents, and restricted cash at end of period $ 2,396.7 $ 2,021.8